72/100BSynopsys stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Synopsys is 575.93, 27.9% above the current price of 450.38. Their targets range from 420.00 to 700.00.
Of the 15 firms that rated Synopsys in the past 12 months, 14 rate it buy or strong buy, 1 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 420.00 to 700.00, with an average of 575.93.
| Buy | 14 | |
| Hold | 1 | |
| Sell | 0 |
12-month price target
| Highest target | 700.00 |
| Average target | 575.93 |
| Lowest target | 420.00 |
| Current price | 450.38 |
Synopsys price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Synopsys price target and rating?
How analysts rate Synopsys, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
14 of 15 firms rate it buy now, against 10 of 12 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Synopsys analyst upgrades, downgrades and price targets
The latest rating change came on 25 September 2026, when HSBC upgraded Synopsys from Hold to Buy. Its price target is 700.00, from 455.00. The most recent new target came from Needham on 12 October 2026: 620.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 12 Oct 2026 | Needham Charles Shi | Reiterated · Buy | 580.00 → 620.00 | +6.9% | 509.99 |
| 1 Oct 2026 | Deutsche Bank | — | 640.00 | — | 479.50 |
| 1 Oct 2026 | KeyBanc | Reiterated · Overweight | 600.00 → 605.00 | +0.8% | 434.94 |
| 1 Oct 2026 | Wells Fargo | Reiterated · Overweight | 475.00 → 540.00 | +13.7% | 434.94 |
| 25 Sept 2026 | HSBC Frank Lee | Upgraded · Hold → Buy | 455.00 → 700.00 | +53.8% | 424.91 |
| 24 Sept 2026 | BNP Paribas | Upgraded · Underperform → Neutral | 425.00 → 420.00 | -1.2% | 413.06 |
| 10 Sept 2026 | Wells Fargo Joe Quatrochi | Upgraded · Equal Weight → Overweight | 450.00 → 475.00 | +5.6% | 393.22 |
| 8 Sept 2026 | Morgan Stanley | Upgraded · Equal Weight → Overweight | — | — | — |
| 27 Aug 2026 | UBS | — | 570.00 | — | 453.81 |
| 27 Aug 2026 | Mizuho Securities | Reiterated · Outperform | 550.00 | — | 410.00 |
| 27 Aug 2026 | Robert W. Baird Jon Vruwink | — | 558.00 → 560.00 | +0.4% | 410.00 |
| 27 Aug 2026 | Baird | Upgraded · Neutral → Outperform | — | — | — |
| 25 Aug 2026 | Rosenblatt Securities Blair Abernethy | Reiterated · Buy | 575.00 | — | 394.51 |
| 19 Aug 2026 | Morgan Stanley Lee Simpson | Reiterated · Equal Weight | 525.00 → 500.00 | -4.8% | 405.48 |
| 11 Aug 2026 | Wells Fargo | Reiterated · Equal Weight | 535.00 → 450.00 | -15.9% | 411.68 |
| 23 Jun 2026 | Piper Sandler Clarke Jeffries | Upgraded · Neutral → Overweight | 450.00 → 550.00 | +22.2% | 464.58 |
| 28 May 2026 | Piper Sandler | Reiterated · Neutral | 520.00 → 450.00 | -13.5% | 487.76 |
| 28 May 2026 | Stifel Nicolaus Ruben Roy | Reiterated · Buy | 600.00 | — | 525.92 |
| 28 May 2026 | Robert W. Baird | — | 535.00 → 558.00 | +4.3% | 525.92 |
| 28 May 2026 | Wells Fargo Joe Quatrochi | Reiterated · Equal Weight | 500.00 → 535.00 | +7.0% | 525.92 |
| 28 May 2026 | Morgan Stanley Lee Simpson | Reiterated · Equal Weight | 550.00 → 525.00 | -4.5% | 525.92 |
| 27 May 2026 | Berenberg Bank | — | 633.00 | — | 534.56 |
| 27 Feb 2026 | Morgan Stanley | Downgraded · Overweight → Equal Weight | — | — | — |
| 25 Feb 2026 | Goldman Sachs James Schneider | — | 600.00 | — | 449.17 |
| 20 Feb 2026 | HSBC | — | 455.00 | — | 444.62 |
| 13 Jan 2026 | Piper Sandler | Downgraded · Overweight → Neutral | 602.00 → 520.00 | -13.6% | 533.42 |
| 12 Dec 2025 | Morgan Stanley | Reiterated · Overweight | 550.00 | — | 462.05 |
| 11 Dec 2025 | Needham | Reiterated · Buy | 550.00 → 580.00 | +5.5% | 470.90 |
| 11 Dec 2025 | Piper Sandler | Reiterated · Overweight | 630.00 → 602.00 | -4.4% | 475.73 |
| 11 Dec 2025 | Wells Fargo Joe Quatrochi | Reiterated · Equal Weight | 445.00 → 500.00 | +12.4% | 475.73 |
| 11 Dec 2025 | KeyBanc Jason Celino | Reiterated · Overweight | 590.00 → 600.00 | +1.7% | 475.73 |
| 11 Dec 2025 | B of A Securities | Upgraded · Neutral → Buy | — | — | — |
| 9 Dec 2025 | Rosenblatt | Upgraded · Neutral → Buy | — | — | — |
| 8 Dec 2025 | B of A Securities | Upgraded · Underperform → Neutral | — | — | — |
| 25 Nov 2025 | Wells Fargo Joe Quatrochi | Reiterated · Equal Weight | 550.00 → 445.00 | -19.1% | 404.63 |
Synopsys EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Synopsys's EPS to grow 42.5% a year until 2028, faster than over the last 5 years (13.5% a year) and the last 3 years (8.5%).
Analysts expect Synopsys's revenue to grow 21.3% a year until 2028, faster than over the last 5 years (13.9% a year) and the last 3 years (15.2%).
Revenue
EPS
Does Synopsys beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 5.7% off the result, either way, and their revenue estimate 0.7%, over the last 12 quarters.
- EPS beats
- 101 / 134
- Revenue beats
- 94 / 118
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +3.9%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 26 Aug 2026 | 3.67 | 3.91 | +6.5% | 2.44B | 2.48B | +1.6% |
| Q2 FY2026 | 27 May 2026 | 3.15 | 3.35 | +6.3% | 2.25B | 2.28B | +1.1% |
| Q1 FY2026 | 25 Feb 2026 | 3.56 | 3.77 | +5.9% | 2.39B | 2.41B | +0.8% |
| Q4 FY2025 | 10 Dec 2025 | 2.78 | 2.90 | +4.3% | 2.25B | 2.25B | +0.3% |
| Q3 FY2025 | 9 Sept 2025 | 3.80 | 3.39 | -10.8% | 1.77B | 1.74B | -1.6% |
| Q2 FY2025 | 28 May 2025 | 3.39 | 3.67 | +8.3% | 1.60B | 1.60B | +0.2% |
| Q1 FY2025 | 26 Feb 2025 | 2.79 | 3.03 | +8.6% | 1.45B | 1.46B | +0.3% |
| Q4 FY2024 | 4 Dec 2024 | 3.30 | 3.40 | +3.0% | 1.63B | 1.64B | +0.3% |
| Q3 FY2024 | 21 Aug 2024 | 3.28 | 3.43 | +4.6% | 1.52B | 1.53B | +0.4% |
| Q2 FY2024 | 22 May 2024 | 2.95 | 3.00 | +1.7% | 1.44B | 1.46B | +1.0% |
| Q1 FY2024 | 21 Feb 2024 | 3.43 | 3.56 | +3.8% | 1.65B | 1.65B | +0.2% |
| Q4 FY2023 | 29 Nov 2023 | 3.04 | 3.17 | +4.3% | 1.58B | 1.60B | +0.9% |
Synopsys stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Synopsys's earnings grow at the 21.4% a year analysts expect to FY2028, then 15.0% a year, it would earn about 30.76 a share in FY2030. At the P/E it has traded at over the last five years (34.8 to 58.1) that is 1,068.94 to 1,787.16 a share, or 1,492.63 at its average P/E of 48.5. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 15.16 | 526.85 | 735.67 | 880.84 |
| FY2027 | 18.83 | 654.27 | 913.60 | 1,093.87 |
| FY2028 | 23.26 | 808.27 | 1,128.65 | 1,351.35 |
| FY2029 (extrapolated) | 26.75 | 929.51 | 1,297.94 | 1,554.05 |
| FY2030 (extrapolated) | 30.76 | 1,068.94 | 1,492.63 | 1,787.16 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (34.8, 48.5, 58.1).
Is Synopsys stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Synopsys's P/E of 78.2 is near the top of its 5-year range (32.9 to 118.6, median 63.6). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay less for each point of growth than usual: a PEG of 1.8 on expected growth against 4.7 on its median P/E and past five years' growth. Fair value is not a reliable guide for Synopsys: its earnings swing (EPS fell 44.6% in FY2025), so its usual P/E would mislead. Its forward P/E, on the consensus for FY2027, is 23.9.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 78.19
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 63.58
- Five-year P/E range
- 32.9 – 118.6
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 23.92
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 3.65
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +27.9%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 194.93146Price 99.09244 | +96.7% | |
| 42.225 | 82.9546Price 42.23165 | +96.4% | |
| 186.680 | 360.82271Price 186.68451 | +93.3% | |
| 213.670 | 405.57304Price 213.67507 | +89.8% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 160.650 | 300.09225Price 160.65375 | +86.8% | |
| 165.860 | 308.95212Price 165.86442 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.